Australia's largest stock trading and investment forum Australia's #1 stock forum

STTrading weekend thread 8th and 9th of March 2025, page-42

First 42 Last

Share
Profile

Follow
wrighty64

6,515 Posts.

335

18/03/25

21:39

Post #: 78318476
Share

Originally posted by ammie: ↑

STTCOMP OCC FA Long

Orthocell
Market cap - around $300m
Share Price - $1.24

Orthocell submitted its application in December for FDA approval to distribute their Remplir product into the US. Remplir is used for repair of nerves. The remplir product is already approved and used in Australia, NZ & Singapore. If they get US approval, that will be a major step up in their potential revenue. The approval is expected in late March or early April, hence tipping now. Revenue is growing but the company is still operating at a loss.
As with all FDA applications, there is a risk that they won't get the approval.

Expand

Hey whats going on here Ammie snuck in the back door ya cheeky bugger.
1 Upvote

0 Great analysis

Reply

Top Stories

NUZ

Neurizon inks $1.5M loan against R&D Tax Rebate

ASX Market Close: Index rebounds as investors buoyant | July 30, 2025

HAR

Haranga jumps +7% on Lincoln acquisition

HotCopper Trends: Wall of quarterlies dominate; then there's Micro-X & Ionic

IXR

Ionic Rare Earths falls -7% as momentum slips on vague production update

First 42 Last